In patients with refractory lupus nephritis, eculizumab can be considered in multi-refractory cases. Eculizumab is a recombinant humanized monoclonal antibody (mAb) that binds to the complement component C5 and prevents its activation (80). The gene discussed is C5; the disease is lupus nephritis.